3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Rectal Neoplasms
22
Triple Negative Breast Neoplasms
16
Stomach Neoplasms
16
Colorectal Neoplasms
13
Neoplasm Metastasis
9
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
7
Neoplasms
5
Nasopharyngeal Carcinoma
5
Biliary Tract Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Interventions
Specimen Handling
51
Carboplatin
49
pembrolizumab
45
Magnetic Resonance Spectroscopy
43
Pemetrexed
39
Cisplatin
34
Paclitaxel
24
durvalumab
23
osimertinib
20
Nivolumab
19
Gemcitabine
19
Radiosurgery
17
Docetaxel
17
atezolizumab
14
Taxes
12
Radiotherapy
12
Immunoglobulin G
12
Disulfides
12
130-nm albumin-bound paclitaxel
12
Etoposide
11
Educational Status
11
Biopsy
11
Radiation
10
Drug Therapy
10
Blood Specimen Collection
10
Platinum
9
Early Intervention, Educational
9
Cetuximab
9
Methods
8
Bevacizumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Capecitabine
×
90 days
×
Clear all
No trials found.